Nausea, vomiting and Anorexia. Nausea and vomiting
Conditions
Interventions
Intervention 1: Intervention group: The samples are assigned to two random groups as quadruple random blocks A, A, B, and B. First, written and informed consent was obtained from the patients. Then, w
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: Written conset to participate in the study Definitive diagnosis of myeloid leukemia and acute lymphocytic (ALL and AML) by a pediatric hematologist and oncologist (other than None M3ALL ) Receiving chemotherapy courses History of receiving at least one course of chemotherapy Experience of nausea following previous chemotherapy sessions No concomitant radiotherapy with chemotherapy Age 3 to 18 years
Exclusion criteria
Exclusion criteria: Using medications or other treatments to reduce nausea other than the usual prescribed anti-nausea and vomiting medications (especially herbal remedies) Nausea and vomiting resistant to treatment Unwillingness to participating in the study sensitivity to mint other nausea problems such as hypertention , liver failure , kidney and digestive problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale.;Vomiting. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale.;Anorexia. Timepoint: Before, immediately, 24 hours, 48 hours after chemotherapy. Method of measurement: VAS questionnaire and measurement table and Face scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Akbari
Khomein University of Medical Sciences
Outcome results
None listed